arrow
S

Simon Hanft

newyork medical college
H指数:17
被引数:1,062

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interim Analysis of a Phase 3 Randomized Controlled Trial of Post-Operative Stereotactic Radiotherapy versus Surgically Targeted Radiation Therapy With GammaTile® for Treatment of Newly Diagnosed Metastatic Brain Tumors (ROADS, NCT04365374)

III期随机对照试验中期分析:术后立体定向放射治疗与使用GammaTile®的手术靶向放射治疗治疗新诊断脑转移瘤的比较(ROADS,NCT04365374)

2026-04-010
PRE
Local control and leptomeningeal disease after resection and GammaTile brachytherapy for newly diagnosed brain metastases: results from a prospective registry

局部控制和软脑膜病变:新诊断脑转移瘤切除术及GammaTile近距离放射治疗后的结果——来自一项前瞻性登记研究

2026-02-070
OAAI
RADT-74. SURGICALLY TARGETED RADIATION THERAPY FOR RECURRENT GRADE IV GLIOMAS: INITIAL RESULTS FROM A MULTICENTER PROSPECTIVE COHORT STUDY

RADT-74. 外科靶向放射疗法治疗复发性四级胶质瘤:多中心前瞻性队列研究的初步结果

2025-11-110
OA
SURGICALLY TARGETED RADIATION THERAPY (START) FOR RECURRENT MENINGIOMA: INITIAL REPORT ON A MULTI-INSTITUTIONAL PROSPECTIVE STUDY

手术靶向放射疗法(START)治疗复发性脑膜瘤:一项多中心前瞻性研究的初步报告

2025-11-010
OAAI
Rate of infection after craniotomy for brain tumor resection and permanent implantation of surgically targeted radiation therapy: initial report on the first 250 consecutive patients from a multi-institutional prospective study

脑肿瘤切除术开颅术后感染率及手术靶向放射治疗的永久植入:一项多中心前瞻性研究首批250例连续患者的初步报告

2025-11-010
OAAI
SURGICALLY TARGETED RADIATION THERAPY (START) FOR PREVIOUSLY IRRADIATED RECURRENT BRAIN METASTASES: INITIAL REPORT FROM A MULTI-INSTITUTIONAL PROSPECTIVE STUDY

手术靶向放射治疗(START)用于先前接受过放射治疗的复发脑转移瘤:一项多中心前瞻性研究的初步报告

2025-11-010
OAAI
Gammatile Brachytherapy Safety and Efficacy in Recurrent Glioblastoma Patients: Outcomes from a Multi-Institutional Collaborative

伽玛刀近距离治疗在复发胶质母细胞瘤患者中的安全性与有效性:多机构协作的成果

2025-11-010
OAAI
Pathologic Incidence of Tumor Positivity Versus Necrosis After Prior Radiotherapy in Patients Undergoing Craniotomy and Resection for Presumed Recurrent Brain Metastasis: Insights from a Prospective Multi-Institutional Registry
2025-04-010
PRE
RECURRENT BRAIN METASTASES (RBM) TREATED WITH SURGICALLY TARGETED RADIATION THERAPY (START): PRELIMINARY SAFETY EVALUATION FROM A MULTI-INSTITUTIONAL PROSPECTIVE REGISTRY
2024-11-110
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
2024-11-110
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA
2024-10-170
PRE